Jul 17, 2025 06:44AM

Nov 13, 2024 04:05PM

Mar 29, 2024 08:30AM

Aug 11, 2023 08:30AM

Jun 6, 2023 08:00AM

Jun 5, 2023 05:55AM

Jun 3, 2023 09:00AM Elicio Therapeutics Announces Positive Interim Data from the Phase 1 Study of an Investigational Therapeutic Cancer Immunotherapy, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal

Jun 1, 2023 04:04PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All